Egyptian Drug Authority · Egypt
DEA-EG-2026-0016
Tier 1 · Regulator-publishedClass IIسحبStatus · active
- Issuing authority
- Egyptian Drug Authority (EDA)
- Authority reference
- Periodic report no.(16) For 2026
- Date issued
- Mar 2026
- Recorded by us
- 2026-09-06 19:45:29 UTC
- المستحضر
- Adport 1 mg Hard gelatin capsules
- INN / active substance
- Not stated by the issuing authority
- Dosage form
- Not stated by the issuing authority
- Strength
- Not stated by the issuing authority
- الشركة المصنعة
- Sandoz Egypt Pharma
- Manufacturer country
- Not stated by the issuing authority
- MAH or importer
- Not stated by the issuing authority
- أرقام التشغيلات
- PM4379 · PC3053
- تواريخ انتهاء الصلاحية
- Not published with the notice
- Action type
- سحب
- التصنيف
- Class II as issued
- Indicative severity
- Not assessed by Drug Eye Africa
- Defect category
- Not stated by the issuing authority
- Product type
- Not stated by the issuing authority
- ATC code
- Not stated by the issuing authority
- Affected markets
- Egypt — no market beyond the issuing country was named on the notice
- Cross-border event
- Not linked to a cross-border event
- نص الإخطار
- Adport 1 mg Hard gelatin capsules
Sandoz Egypt Pharma
PM4379-PC3053
1/2027-5/2026
صدور عدم مطابقة لهذهالتشغيلةمن
معامل هيئة الدواء المصرية
وقف تداول و ضبط وتحريز التشغيلةمن
المستحضر الصادر لها عدم مطابقة
في حالة الشك في المستحضر الصيدلى يتم
الرجوع إلى هيئة الدواء المصرية سواء
بالإتصال بالخط الساخن 15301او الموقع
الإلكترونى الخاص بالهيئة.
مارس 2026
اسم المستحضر
رقم التشغيلة
سبب التحذير
الإجراءات
التصحيحية
نصائح
للمستهلكين
منشور
سحب
الشركة صاحبةالمستحضر
هذا التنبية خاص بالتشغيلات الواردة في المنشور فقط ولا ينطبق على
تداول المستحضر بشكل عام
تاريخ الانتهاءOriginal language: ar
- نص الإخطار بالإنجليزية
- Halt of circulation and seizure. Adport 1 mg hard gelatin capsules, of Sandoz Egypt Pharma, batches PM4379 and PC3053, expiries 1/2027 and 5/2026. A finding of non-conformity has been issued for this batch by the Egyptian Drug Authority laboratories.Machine translation, produced by Drug Eye Africa and not checked by the issuing authority. The authority stated only the text above it.
- الحالة
- سارٍ
- Superseded by
- Not superseded. This is the current version.
- Version
- 12
Where this record came from, and what is held to show it.
- Copy of the source
- Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.Ask us for it and check it against the fingerprint below.
- Fingerprint
- 3070a7dd183a0430a4ca65c845e973ad59596f25d9d4e6f85ba1f103526e6468SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
- Copy taken
- 2026-09-06 20:48:56 UTC
Cite this record
Drug Eye Africa (2026). DEA-EG-2026-0016: Adport 1 mg Hard gelatin capsules — سحب, Egyptian Drug Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/eg/2026/dea-eg-2026-0016Version history
—No version history recorded for this record.
—Corrections appear here and in the site-wide log. Records are superseded, never deleted.
Verification
Tier 1 — Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.
Indexing
This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.